Liposomal and Lipid Nanoparticle Drug Delivery Systems Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Liposomal and Lipid Nanoparticle Drug Delivery Systems
1.2 Key Market Segments
1.2.1 Liposomal and Lipid Nanoparticle Drug Delivery Systems Segment by Type
1.2.2 Liposomal and Lipid Nanoparticle Drug Delivery Systems Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Overview
2.1 Global Market Overview
2.1.1 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Competitive Landscape
3.1 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Manufacturers (2019-2024)
3.2 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Market Share by Manufacturers (2019-2024)
3.3 Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Sites, Area Served, Product Type
3.6 Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Competitive Situation and Trends
3.6.1 Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Concentration Rate
3.6.2 Global 5 and 10 Largest Liposomal and Lipid Nanoparticle Drug Delivery Systems Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Liposomal and Lipid Nanoparticle Drug Delivery Systems Industry Chain Analysis
4.1 Liposomal and Lipid Nanoparticle Drug Delivery Systems Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Liposomal and Lipid Nanoparticle Drug Delivery Systems Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Market Share by Type (2019-2024)
6.3 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Market Share by Type (2019-2024)
6.4 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Price by Type (2019-2024)
7 Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Sales by Application (2019-2024)
7.3 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size (M USD) by Application (2019-2024)
7.4 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Growth Rate by Application (2019-2024)
8 Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Segmentation by Region
8.1 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Region
8.1.1 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Region
8.1.2 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Market Share by Region
8.2 North America
8.2.1 North America Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Johnson and Johnson
9.1.1 Johnson and Johnson Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.1.2 Johnson and Johnson Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.1.3 Johnson and Johnson Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.1.4 Johnson and Johnson Business Overview
9.1.5 Johnson and Johnson Liposomal and Lipid Nanoparticle Drug Delivery Systems SWOT Analysis
9.1.6 Johnson and Johnson Recent Developments
9.2 Sun Pharmaceutical
9.2.1 Sun Pharmaceutical Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.2.2 Sun Pharmaceutical Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.2.3 Sun Pharmaceutical Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.2.4 Sun Pharmaceutical Business Overview
9.2.5 Sun Pharmaceutical Liposomal and Lipid Nanoparticle Drug Delivery Systems SWOT Analysis
9.2.6 Sun Pharmaceutical Recent Developments
9.3 CSPC
9.3.1 CSPC Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.3.2 CSPC Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.3.3 CSPC Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.3.4 CSPC Liposomal and Lipid Nanoparticle Drug Delivery Systems SWOT Analysis
9.3.5 CSPC Business Overview
9.3.6 CSPC Recent Developments
9.4 Kinyond
9.4.1 Kinyond Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.4.2 Kinyond Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.4.3 Kinyond Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.4.4 Kinyond Business Overview
9.4.5 Kinyond Recent Developments
9.5 Teva
9.5.1 Teva Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.5.2 Teva Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.5.3 Teva Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.5.4 Teva Business Overview
9.5.5 Teva Recent Developments
9.6 Fudan-Zhangjiang
9.6.1 Fudan-Zhangjiang Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.6.2 Fudan-Zhangjiang Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.6.3 Fudan-Zhangjiang Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.6.4 Fudan-Zhangjiang Business Overview
9.6.5 Fudan-Zhangjiang Recent Developments
9.7 Zydus Cadila
9.7.1 Zydus Cadila Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.7.2 Zydus Cadila Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.7.3 Zydus Cadila Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.7.4 Zydus Cadila Business Overview
9.7.5 Zydus Cadila Recent Developments
9.8 TTY Biopharma
9.8.1 TTY Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.8.2 TTY Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.8.3 TTY Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.8.4 TTY Biopharma Business Overview
9.8.5 TTY Biopharma Recent Developments
9.9 Pacira
9.9.1 Pacira Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.9.2 Pacira Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.9.3 Pacira Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.9.4 Pacira Business Overview
9.9.5 Pacira Recent Developments
9.10 Luye Pharma
9.10.1 Luye Pharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.10.2 Luye Pharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.10.3 Luye Pharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.10.4 Luye Pharma Business Overview
9.10.5 Luye Pharma Recent Developments
9.11 Leadiant Biosciences
9.11.1 Leadiant Biosciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.11.2 Leadiant Biosciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.11.3 Leadiant Biosciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.11.4 Leadiant Biosciences Business Overview
9.11.5 Leadiant Biosciences Recent Developments
9.12 Ipsen
9.12.1 Ipsen Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.12.2 Ipsen Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.12.3 Ipsen Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.12.4 Ipsen Business Overview
9.12.5 Ipsen Recent Developments
9.13 Sayre Therapeutics
9.13.1 Sayre Therapeutics Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.13.2 Sayre Therapeutics Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.13.3 Sayre Therapeutics Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.13.4 Sayre Therapeutics Business Overview
9.13.5 Sayre Therapeutics Recent Developments
9.14 Jazz
9.14.1 Jazz Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.14.2 Jazz Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.14.3 Jazz Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.14.4 Jazz Business Overview
9.14.5 Jazz Recent Developments
9.15 Alnylam
9.15.1 Alnylam Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.15.2 Alnylam Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.15.3 Alnylam Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.15.4 Alnylam Business Overview
9.15.5 Alnylam Recent Developments
9.16 Bausch Health
9.16.1 Bausch Health Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.16.2 Bausch Health Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.16.3 Bausch Health Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.16.4 Bausch Health Business Overview
9.16.5 Bausch Health Recent Developments
9.17 Acrotech Biopharma
9.17.1 Acrotech Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.17.2 Acrotech Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.17.3 Acrotech Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.17.4 Acrotech Biopharma Business Overview
9.17.5 Acrotech Biopharma Recent Developments
9.18 Takeda
9.18.1 Takeda Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.18.2 Takeda Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.18.3 Takeda Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.18.4 Takeda Business Overview
9.18.5 Takeda Recent Developments
9.19 Chiesi Farmaceutici
9.19.1 Chiesi Farmaceutici Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.19.2 Chiesi Farmaceutici Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.19.3 Chiesi Farmaceutici Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.19.4 Chiesi Farmaceutici Business Overview
9.19.5 Chiesi Farmaceutici Recent Developments
9.20 Gilead Sciences
9.20.1 Gilead Sciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
9.20.2 Gilead Sciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
9.20.3 Gilead Sciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Market Performance
9.20.4 Gilead Sciences Business Overview
9.20.5 Gilead Sciences Recent Developments
10 Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Forecast by Region
10.1 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Forecast
10.2 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Forecast by Country
10.2.3 Asia Pacific Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Forecast by Region
10.2.4 South America Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Liposomal and Lipid Nanoparticle Drug Delivery Systems by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Liposomal and Lipid Nanoparticle Drug Delivery Systems by Type (2025-2030)
11.1.2 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Liposomal and Lipid Nanoparticle Drug Delivery Systems by Type (2025-2030)
11.2 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Forecast by Application (2025-2030)
11.2.1 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons) Forecast by Application
11.2.2 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Comparison by Region (M USD)
Table 5. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal and Lipid Nanoparticle Drug Delivery Systems as of 2022)
Table 10. Global Market Liposomal and Lipid Nanoparticle Drug Delivery Systems Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Sites and Area Served
Table 12. Manufacturers Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Type
Table 13. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Liposomal and Lipid Nanoparticle Drug Delivery Systems
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Challenges
Table 22. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Type (Kilotons)
Table 23. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Type (M USD)
Table 24. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons) by Type (2019-2024)
Table 25. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Market Share by Type (2019-2024)
Table 26. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size (M USD) by Type (2019-2024)
Table 27. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Share by Type (2019-2024)
Table 28. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Price (USD/Ton) by Type (2019-2024)
Table 29. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons) by Application
Table 30. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Application
Table 31. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Market Share by Application (2019-2024)
Table 33. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Application (2019-2024) & (M USD)
Table 34. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Share by Application (2019-2024)
Table 35. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Growth Rate by Application (2019-2024)
Table 36. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Market Share by Region (2019-2024)
Table 38. North America Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales by Region (2019-2024) & (Kilotons)
Table 43. Johnson and Johnson Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 44. Johnson and Johnson Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 45. Johnson and Johnson Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Johnson and Johnson Business Overview
Table 47. Johnson and Johnson Liposomal and Lipid Nanoparticle Drug Delivery Systems SWOT Analysis
Table 48. Johnson and Johnson Recent Developments
Table 49. Sun Pharmaceutical Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 50. Sun Pharmaceutical Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 51. Sun Pharmaceutical Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Sun Pharmaceutical Business Overview
Table 53. Sun Pharmaceutical Liposomal and Lipid Nanoparticle Drug Delivery Systems SWOT Analysis
Table 54. Sun Pharmaceutical Recent Developments
Table 55. CSPC Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 56. CSPC Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 57. CSPC Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. CSPC Liposomal and Lipid Nanoparticle Drug Delivery Systems SWOT Analysis
Table 59. CSPC Business Overview
Table 60. CSPC Recent Developments
Table 61. Kinyond Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 62. Kinyond Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 63. Kinyond Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Kinyond Business Overview
Table 65. Kinyond Recent Developments
Table 66. Teva Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 67. Teva Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 68. Teva Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Teva Business Overview
Table 70. Teva Recent Developments
Table 71. Fudan-Zhangjiang Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 72. Fudan-Zhangjiang Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 73. Fudan-Zhangjiang Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Fudan-Zhangjiang Business Overview
Table 75. Fudan-Zhangjiang Recent Developments
Table 76. Zydus Cadila Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 77. Zydus Cadila Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 78. Zydus Cadila Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Zydus Cadila Business Overview
Table 80. Zydus Cadila Recent Developments
Table 81. TTY Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 82. TTY Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 83. TTY Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. TTY Biopharma Business Overview
Table 85. TTY Biopharma Recent Developments
Table 86. Pacira Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 87. Pacira Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 88. Pacira Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Pacira Business Overview
Table 90. Pacira Recent Developments
Table 91. Luye Pharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 92. Luye Pharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 93. Luye Pharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Luye Pharma Business Overview
Table 95. Luye Pharma Recent Developments
Table 96. Leadiant Biosciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 97. Leadiant Biosciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 98. Leadiant Biosciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Leadiant Biosciences Business Overview
Table 100. Leadiant Biosciences Recent Developments
Table 101. Ipsen Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 102. Ipsen Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 103. Ipsen Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Ipsen Business Overview
Table 105. Ipsen Recent Developments
Table 106. Sayre Therapeutics Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 107. Sayre Therapeutics Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 108. Sayre Therapeutics Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Sayre Therapeutics Business Overview
Table 110. Sayre Therapeutics Recent Developments
Table 111. Jazz Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 112. Jazz Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 113. Jazz Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Jazz Business Overview
Table 115. Jazz Recent Developments
Table 116. Alnylam Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 117. Alnylam Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 118. Alnylam Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Alnylam Business Overview
Table 120. Alnylam Recent Developments
Table 121. Bausch Health Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 122. Bausch Health Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 123. Bausch Health Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Bausch Health Business Overview
Table 125. Bausch Health Recent Developments
Table 126. Acrotech Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 127. Acrotech Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 128. Acrotech Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Acrotech Biopharma Business Overview
Table 130. Acrotech Biopharma Recent Developments
Table 131. Takeda Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 132. Takeda Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 133. Takeda Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Takeda Business Overview
Table 135. Takeda Recent Developments
Table 136. Chiesi Farmaceutici Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 137. Chiesi Farmaceutici Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 138. Chiesi Farmaceutici Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Chiesi Farmaceutici Business Overview
Table 140. Chiesi Farmaceutici Recent Developments
Table 141. Gilead Sciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Basic Information
Table 142. Gilead Sciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Overview
Table 143. Gilead Sciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Gilead Sciences Business Overview
Table 145. Gilead Sciences Recent Developments
Table 146. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Forecast by Region (2025-2030) & (Kilotons)
Table 147. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Forecast by Country (2025-2030) & (Kilotons)
Table 149. North America Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Forecast by Country (2025-2030) & (Kilotons)
Table 151. Europe Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Forecast by Region (2025-2030) & (Kilotons)
Table 153. Asia Pacific Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Forecast by Country (2025-2030) & (Kilotons)
Table 155. South America Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Liposomal and Lipid Nanoparticle Drug Delivery Systems Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Forecast by Type (2025-2030) & (Kilotons)
Table 159. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Price Forecast by Type (2025-2030) & (USD/Ton)
Table 161. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons) Forecast by Application (2025-2030)
Table 162. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Liposomal and Lipid Nanoparticle Drug Delivery Systems
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size (M USD), 2019-2030
Figure 5. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size (M USD) (2019-2030)
Figure 6. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Country (M USD)
Figure 11. Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Share by Manufacturers in 2023
Figure 12. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Share by Manufacturers in 2023
Figure 13. Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Liposomal and Lipid Nanoparticle Drug Delivery Systems Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Share by Type
Figure 18. Sales Market Share of Liposomal and Lipid Nanoparticle Drug Delivery Systems by Type (2019-2024)
Figure 19. Sales Market Share of Liposomal and Lipid Nanoparticle Drug Delivery Systems by Type in 2023
Figure 20. Market Size Share of Liposomal and Lipid Nanoparticle Drug Delivery Systems by Type (2019-2024)
Figure 21. Market Size Market Share of Liposomal and Lipid Nanoparticle Drug Delivery Systems by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Share by Application
Figure 24. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Market Share by Application (2019-2024)
Figure 25. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Market Share by Application in 2023
Figure 26. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Share by Application (2019-2024)
Figure 27. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Share by Application in 2023
Figure 28. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Growth Rate by Application (2019-2024)
Figure 29. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Market Share by Region (2019-2024)
Figure 30. North America Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Market Share by Country in 2023
Figure 32. U.S. Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Market Share by Country in 2023
Figure 37. Germany Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Market Share by Region in 2023
Figure 44. China Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (Kilotons)
Figure 50. South America Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Market Share by Country in 2023
Figure 51. Brazil Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Share Forecast by Type (2025-2030)
Figure 65. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Forecast by Application (2025-2030)
Figure 66. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Share Forecast by Application (2025-2030)
Industry Market Size
